位置:首页 > 蛋白库 > BRKP1_AGADC
BRKP1_AGADC
ID   BRKP1_AGADC             Reviewed;          61 AA.
AC   L0PIN3;
DT   15-FEB-2017, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2013, sequence version 1.
DT   25-MAY-2022, entry version 27.
DE   RecName: Full=[Thr6]-bradykinyl-Val,Asp {ECO:0000303|PubMed:24394432};
DE   AltName: Full=Bradykinin-related peptide RD-11 {ECO:0000303|PubMed:24394432};
DE   Contains:
DE     RecName: Full=[Thr6]-bradykinin {ECO:0000303|PubMed:24394432};
DE   Flags: Precursor;
OS   Agalychnis dacnicolor (Giant mexican leaf frog) (Pachymedusa dacnicolor).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Neobatrachia; Hyloidea; Hylidae; Phyllomedusinae;
OC   Agalychnis.
OX   NCBI_TaxID=75988 {ECO:0000312|EMBL:CCJ67650.1};
RN   [1] {ECO:0000312|EMBL:CCJ67650.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 51-61, FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MASS SPECTROMETRY, HYDROXYLATION
RP   AT PRO-53, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Skin {ECO:0000312|EMBL:CCJ67650.1}, and
RC   Skin secretion {ECO:0000303|PubMed:24394432};
RX   PubMed=24394432; DOI=10.1016/j.peptides.2013.12.013;
RA   Jiang Y., Xi X., Ge L., Yang N., Hou X., Ma J., Ma C., Wu Y., Guo X.,
RA   Li R., Zhou M., Wang L., Chen T., Shaw C.;
RT   "Bradykinin-related peptides (BRPs) from skin secretions of three genera of
RT   phyllomedusine leaf frogs and their comparative pharmacological effects on
RT   mammalian smooth muscles.";
RL   Peptides 52:122-133(2014).
CC   -!- FUNCTION: [[Thr6]-bradykinin]: Induces relaxation of rat smooth muscle
CC       from tail artery (EC(50)=16.8 nM) and contraction of that from ileum
CC       (EC(50)=205 nM), urinary bladder (EC(50)=895 nM) and uterus
CC       (EC(50)=60.3 nM). Binds to both bradykinin receptor B1 (BDKRB1) and B2
CC       (BDKRB2). {ECO:0000269|PubMed:24394432}.
CC   -!- FUNCTION: [Hyp3,Thr6]-bradykinin: Induces relaxation of rat smooth
CC       muscle from tail artery (EC(50)=56.7 nM) and contraction of that from
CC       ileum (EC(50)=588 nM), urinary bladder (EC(50)=4.6 uM) and uterus
CC       (EC(50)=3.9 nM). Binds to both bradykinin receptor B1 (BDKRB1) and B2
CC       (BDKRB2). In arterial smooth muscle, the effect via BDKRB1 is stronger,
CC       in uterus, ileum and urinary bladder the effect via BDKRB2.
CC       {ECO:0000269|PubMed:24394432}.
CC   -!- FUNCTION: [[Thr6]-bradykinyl-Val,Asp]: Induces relaxation of rat smooth
CC       muscle from tail artery (EC(50)=10.8 nM) and contraction of that from
CC       ileum (EC(50)=645 nM), urinary bladder (EC(50)=1.1 uM) and uterus
CC       (EC(50)=1.2 uM). Binds to both bradykinin receptor B1 (BDKRB1) and B2
CC       (BDKRB2). Apart from uterus smooth muscle, the effect via BDKRB2 is
CC       stronger. {ECO:0000269|PubMed:24394432}.
CC   -!- FUNCTION: [Hyp3,Thr6]-bradykinyl-Val,Asp: Induces relaxation of rat
CC       smooth muscle from tail artery (EC(50)=3.5 nM) and contraction of that
CC       from ileum (EC(50)=223 nM), urinary bladder (EC(50)=1.5 uM) and uterus
CC       (EC(50)=356 nM). Binds to both bradykinin receptor B1 (BDKRB1) and B2
CC       (BDKRB2); the effects via BDKRB2 are stronger.
CC       {ECO:0000269|PubMed:24394432}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000255,
CC       ECO:0000269|PubMed:24394432}.
CC   -!- TISSUE SPECIFICITY: Expressed by the skin glands.
CC       {ECO:0000305|PubMed:24394432}.
CC   -!- MASS SPECTROMETRY: [[Thr6]-bradykinyl-Val,Asp]: Mass=1303.55;
CC       Method=MALDI; Note=[Hyp3,Thr6]-bradykinyl-Val,Asp.;
CC       Evidence={ECO:0000269|PubMed:24394432};
CC   -!- MASS SPECTROMETRY: [[Thr6]-bradykinyl-Val,Asp]: Mass=1287.90;
CC       Method=MALDI; Note=[Thr6]-bradykinyl-Val,Asp.;
CC       Evidence={ECO:0000269|PubMed:24394432};
CC   -!- MASS SPECTROMETRY: [[Thr6]-bradykinin]: Mass=1089.70; Method=MALDI;
CC       Note=[Hyp3,Thr6]-bradykinin.; Evidence={ECO:0000269|PubMed:24394432};
CC   -!- MASS SPECTROMETRY: [[Thr6]-bradykinin]: Mass=1073.45; Method=MALDI;
CC       Note=[Thr6]-bradykinin.; Evidence={ECO:0000269|PubMed:24394432};
CC   -!- SIMILARITY: Belongs to the frog skin active peptide (FSAP) family.
CC       Bradykinin-related peptide subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HE967329; CCJ67650.1; -; mRNA.
DR   AlphaFoldDB; L0PIN3; -.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0031712; F:B1 bradykinin receptor binding; IDA:UniProtKB.
DR   GO; GO:0031713; F:B2 bradykinin receptor binding; IDA:UniProtKB.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006952; P:defense response; IEA:UniProtKB-KW.
DR   GO; GO:1905655; P:negative regulation of artery smooth muscle contraction; IDA:UniProtKB.
DR   GO; GO:1904349; P:positive regulation of small intestine smooth muscle contraction; IDA:UniProtKB.
DR   GO; GO:1904320; P:positive regulation of smooth muscle contraction involved in micturition; IDA:UniProtKB.
DR   GO; GO:0070474; P:positive regulation of uterine smooth muscle contraction; IDA:UniProtKB.
DR   GO; GO:0042311; P:vasodilation; IEA:UniProtKB-KW.
DR   InterPro; IPR004275; Frog_antimicrobial_propeptide.
DR   Pfam; PF03032; FSAP_sig_propep; 1.
PE   1: Evidence at protein level;
KW   Amphibian defense peptide; Direct protein sequencing;
KW   G-protein coupled receptor impairing toxin; Hydroxylation; Secreted;
KW   Signal; Toxin; Vasoactive; Vasodilator.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   PROPEP          23..50
FT                   /evidence="ECO:0000305|PubMed:24394432"
FT                   /id="PRO_0000438933"
FT   PEPTIDE         51..61
FT                   /note="[Thr6]-bradykinyl-Val,Asp"
FT                   /evidence="ECO:0000269|PubMed:24394432"
FT                   /id="PRO_0000438934"
FT   PEPTIDE         51..59
FT                   /note="[Thr6]-bradykinin"
FT                   /evidence="ECO:0000269|PubMed:24394432"
FT                   /id="PRO_0000438935"
FT   REGION          24..61
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         53
FT                   /note="4-hydroxyproline; in form [Hyp3,Thr6]-bradykinyl-
FT                   Val,Asp and [Hyp3,Thr6]-bradykinin"
FT                   /evidence="ECO:0000269|PubMed:24394432"
SQ   SEQUENCE   61 AA;  7389 MW;  AD0730EB02116862 CRC64;
     MSFLKKSLFL VLFLGFVSFS ICEEEKREDE EEENEREENK ESEEKRNQEE RPPGFTPFRV
     D
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024